XFOR EPS Estimates
X4 Pharmaceuticals, Inc.
$2.48
+$0.03(+1.22%)
37
Overall
60
Value
18
Tech
34
Quality
Market Cap
$242.91M
Volume
7.52K
52W Range
$2.70 - $4.83
Target Price
$11.60
XFOR EPS estimates: the consensus estimate for X4 Pharmaceuticals, Inc.'s current fiscal year is -$0.67 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
XFOR EPS Estimates
- EPS estimate, current quarter
- $-0.19
- EPS estimate, next quarter
- $-0.20
- EPS estimate, current year
- $-0.67
- EPS estimate, next year
- $-0.73
- EPS growth, 3-year
- +65.52%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.87 |
| 2024 | $-5.70 |
| 2023 | $-17.10 |
| 2022 | $-45.60 |
| 2021 | $-119.70 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | XFOR | $2.48 | +1.2% | 7.52K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get X4 Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW